Renal Cancer Clinical Trials in Beijing, Beijing Municipality
4 recruitingBeijing, Beijing Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Metastatic Renal Cell CarcinomaCarcinoma, Renal CellAdvanced Renal Cell Carcinoma+10 more
Pfizer224 enrolled109 locationsNCT07227415
Recruiting
Not Applicable
CAIX PET/ CT Guided Radiation Therapy in CcRCC.
Metastatic Renal CancerRadiation TherapyRecurrent Renal Cell Cancer
Peking University First Hospital70 enrolled1 locationNCT07540260
Recruiting
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
Metastatic Renal CancerRadiation TherapyRecurrent Renal Cell Cancer
Peking University First Hospital300 enrolled2 locationsNCT06583070
Recruiting
Phase 2
SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC
Targeted TherapyImmunotherapyRadiation Therapy+1 more
Peking University First Hospital30 enrolled1 locationNCT06889649